Evidence map›Paper›PMID 25199775›Full record

ArticleAntimicrobial agents and chemotherapy2014

In Vitro selection of Neisseria gonorrhoeae mutants with elevated MIC values and increased resistance to cephalosporins.

Steven R Johnson, Yonatan Grad, Satishkumar Ranganathan Ganakammal, Mark Burroughs, Mike Frace, Marc Lipsitch, Ryan Weil, David Trees

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Rolling the evolutionary dice:Microbiology spectrum · 2024
    Article
  2. Article
  3. Frontiers in cellular and infection microbiology · 2022
    Article
  4. Article
  5. Article
  6. ShanghaiFrontiers in microbiology · 2020
    Article
  7. In vitro activity of EDTA and TOL-463 against Neisseria gonorrhoeae.Diagnostic microbiology and infectious disease · 2019
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Comparing the disk-diffusion and agar dilution tests forAntimicrobial resistance and infection control · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Steven R JohnsonDivision of STD Prevention, NCHHSTP, Centers for Disease Control and Prevention, Atlanta, Georgia, USA SBJ1@cdc.gov.
Yonatan GradCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Satishkumar Ranganathan GanakammalDivision of Scientific Resources, NCEZID, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mark BurroughsDivision of STD Prevention, NCHHSTP, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Division of Scientific Resources, NCEZID, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mike FraceDivision of Scientific Resources, NCEZID, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Marc LipsitchCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA.
Ryan WeilDivision of Scientific Resources, NCEZID, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
David TreesDivision of STD Prevention, NCHHSTP, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIPSITCH, MARC · 2009 to 2018
$26.4M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefiximeK08AI104767 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI GRAD, YONATAN H · 2013 to 2015
$547k
NIAID NIH HHS K08 AI104767NIAID NIH HHS T32 AI007061NIGMS NIH HHS U54 GM088558NIGMS NIH HHS U54GM088558
6 · The paper itself

Abstract

Strains of Neisseria gonorrhoeae with mosaic penA genes bearing novel point mutations in penA have been isolated from ceftriaxone treatment failures. Such isolates exhibit significantly higher MIC values to third-generation cephalosporins. Here we report the in vitro isolation of two mutants with elevated MICs to cephalosporins. The first possesses a point mutation in the transpeptidase region of the mosaic penA gene, and the second contains an insertion mutation in pilQ.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCephalosporinsDrug Resistance, Multiple, BacterialErythromycinFimbriae ProteinsGonorrheaHumansMicrobial Sensitivity TestsMolecular Sequence DataMutationNeisseria gonorrhoeaePenicillin-Binding ProteinsTreatment FailureAnti-Bacterial Agentsbeta-LactamasesCephalosporinsErythromycinFimbriae ProteinsPenicillin-Binding ProteinspilQ protein, bacteria

Identifiers

PMID25199775
PMCPMC4249396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.